Shareholding disclosure
Kuros Biosciences AG
Collectively declared rate
3.32%
Threshold
Crossed upwards
Timeline
Published
14.05.2015
Transaction
11.05.2015
Voting rights breakdown
Declared beneficial owners · 3
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
Notification ID
TBF5D00033
Beneficial owner
Corey Goodman
Declared address
Corey Goodman, Marshall
Bond conversion into equity. The restructuring of the convertible bonds announced by the Company has been effected. The percentage indicated below is based on the increased share capital of the Company (as per the entry in the commercial register). Warrants and options are directly held by venBio Global Strategic Fund L.P. c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, Georg Town,Grand Cayman KYI-9005, Cayman Islands, which is controlled by venBio Global Strategic GP L.P., c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, George Town, Grand Cayman KYI-9005, Cayman Islands, as general partner. venBio Global Strategic GP L.P, in turn, is controlled by venBio Global Strategic GP Ltd., c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, George Town, Grand Cayman KYI-9005, Cayman Islands, as general partner. venBio Global Strategic GP Ltd. is jointly controlled by Corey Goodman, Marshall, USA, Paul Brooke, New York, USA, and Robert Adelman, Hillsborough, USA. Paul Brooke also hold certain employee options on shares in the Company directly.
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan